According to GuruFocus Insider Data, the recent CFO buys were: Valeant Pharmaceuticals International Inc. (VRX, Financial) and Good Times Restaurants Inc. (GTIM, Financial).
Valeant Pharmaceuticals International Inc.: EVP and CFO Paul Herendeen bought 15,000 shares
EVP and CFO Paul Herendeen bought 15,000 shares for $16.1 per share on Mar. 13. Since then, the stock price has increased by 3.91%. Valeant Pharmaceuticals International Inc. has a market cap of $5.89 billion and its shares were traded around $16.73. The company has a P/E ratio of 2.55 and P/S ratio of 0.66. Over the past 10 years, Valeant Pharmaceuticals International Inc. had an annual average earnings growth of 28.20%.
Valeant Pharmaceuticals International announced its fourth-quarter results with revenue of $2.16 billion and gross profit of $1.52 billion, while the net income was $513 million. The 2017 total revenue was $8.72 billion, a 10% decrease from 2016. The 2017 gross profit was $6.18 billion, a 13% decrease from the year prior. The 2017 net income was $2.4 billion.
Chairman and CEO Joseph C Papa bought 30,000 shares for $16.05 per share on Mar. 13. Since then, the stock price has increased by 4.24%. Senior Officer Paul Herendeen, bought 15,000 shares for $16.1 per share on Mar. 13. Since then, the stock price has increased by 3.91%. Director, Senior Officer Joseph Papa, bought 30,000 shares for $16.05 per share on Mar. 13. Since then, the stock price has increased by 4.24%.
Good Times Restaurants Inc.: CFO Ryan M Zink bought 10,000 shares
CFO Ryan M Zink bought 10,000 shares for $2.7 per share on Mar. 14. Since then, the stock price has increased by 18.52%. Good Times Restaurants Inc. has a market cap of $39.880 million and its shares were traded around $3.20. The company has a P/S ratio of 0.47. Over the past 5 years, Good Times Restaurants Inc. had an annual average earnings growth of 11.10%.
Good Times Restaurants reported revenue of $22.76 million and gross profit of $2.1 million in the fourth quarter, while the net loss was $583,000. Total revenue in 2016 was $79.08 million, a 23% increase from 2015. The 2016 gross profit was $7.58 million, a 0.4% decrease from the year before. The net loss was $2.26 million in 2016.
See Remarks Robert J Stetson bought 601 shares for $2.59 per share on Feb. 22. Since then, the stock price has increased by 23.55%.
Disclosure: none
